MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2025.133887

Медицинская библиотека · International journal of cardiology · 2025

CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD.

Yang Xueqiao, Li Bowen, Chen Huiyu, Ding Ruyue, Chang Na, Ji Congshan, Gu Hui, Wang Ximing

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study aimed to enhance major adverse cardiovascular events (MACEs) prediction by pericoronary adipose tissue attenuation (PCATa) in non-obstructive coronary artery disease (CAD) patients when combined with lipoprotein (a) (Lp(a)).

METHODS

A total of 1052 patients with non-obstructive CAD were included. Detailed clinical data and CCTA features were analyzed. The MACEs in this study was defined as a composite of non-fatal myocardial infarction, new-onset heart failure requiring hospitalization, stroke, all-cause mortality, and coronary revascularization.

RESULTS

During a median follow-up of 6.8 (5.6-7.9) years, 183 (17.4 %) patients suffered from MACEs. Patients experiencing MACEs demonstrated elevated Lp(a) levels and PCATa values (26.20 (17.63-45.08) vs. 12.00 (4.58-26.00), P < 0.001; -72.6 ± 8.4 HU vs. -79.7 ± 9.5 HU, P < 0.001). Lp(a) was associated with PCATa (P < 0.001). Elevated PCATa was associated with quantitatively greater atherosclerotic burden (P < 0.001). Multivariate Cox regression showed that age (HR = 1.03, P = 0.001), hypertension (HR = 1.39, P = 0.036), triglyceride (HR = 1.23, P = 0.003), high-risk plaque (HR = 2.30, P < 0.001), LAPV% (HR = 2.66, P < 0.001), Lp(a) (HR = 1.26, P < 0.001) and PCATa (HR = 1.44, P < 0.001) were independently associated with increased risk of MACEs. Kaplan-Meier analysis demonstrated that patients with Lp(a) ≥30 mg/dL and PCATa > - 78 HU had the highest incidence of MACEs (P < 0.001). Additionally, combination Lp(a) and PCATa showed the highest AUC (P < 0.001).

CONCLUSION

Incorporating Lp(a) and PCATa significantly improves MACEs prediction in non-obstructive CAD patients, where higher Lp(a) levels are linked to elevated PCATa.

Для цитирования: Yang Xueqiao, Li Bowen, Chen Huiyu, Ding Ruyue, Chang Na, Ji Congshan, Gu Hui, Wang Ximing. CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD.. International journal of cardiology. 2025. DOI: 10.1016/j.ijcard.2025.133887.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.